Loading...
XMADCBAV
Market cap525mUSD
Dec 20, Last price  
30.90EUR
1D
-3.13%
1Q
-11.71%
Jan 2017
225.26%
Name

Clinica Baviera SA

Chart & Performance

D1W1MN
XMAD:CBAV chart
P/E
14.00
P/S
2.24
EPS
2.21
Div Yield, %
2.59%
Shrs. gr., 5y
—
Rev. gr., 5y
15.53%
Revenues
225m
+13.34%
43,396,64763,527,04278,381,63287,936,70783,141,22489,682,81493,592,99989,880,51979,975,65082,620,56385,527,35291,572,17699,879,659109,293,546124,333,421122,625,591172,730,250198,449,250224,923,951
Net income
36m
+21.86%
9,378,896-26,285,570-23,666,4287,011,5781,860,8355,239,0395,403,828-87,5874,886,6494,054,8894,879,7167,914,4209,770,09611,826,23712,794,64713,941,69727,389,52729,518,52835,970,928
CFO
58m
+8.31%
015,753,36419,538,92610,262,7058,106,31114,445,15614,526,8938,086,34210,221,3899,664,72610,838,74413,545,58415,831,36416,813,73225,402,08631,455,53046,856,58853,377,07257,812,115
Dividend
Jul 16, 20241.57 EUR/sh
Earnings
Feb 26, 2025

Profile

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Austria, and Italy. The company is based in Madrid, Spain.
URL
https://www.clinicabaviera.com/
IPO date
Jan 01, 2000
Employees
1,423
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
224,924
13.34%
198,449
14.89%
172,730
40.86%
Cost of revenue
53,236
53,708
44,694
Unusual Expense (Income)
NOPBT
171,688
144,741
128,036
NOPBT Margin
76.33%
72.94%
74.12%
Operating Taxes
12,919
10,533
10,968
Tax Rate
7.52%
7.28%
8.57%
NOPAT
158,769
134,208
117,068
Net income
35,971
21.86%
29,519
7.77%
27,390
96.46%
Dividends
(13,042)
(17,188)
(17,348)
Dividend yield
3.48%
6.02%
5.02%
Proceeds from repurchase of equity
5
(20)
12
BB yield
0.00%
0.01%
0.00%
Debt
Debt current
10,655
2,006
11,664
Long-term debt
81,368
73,385
80,720
Deferred revenue
2,365
Other long-term liabilities
3,972
2,464
645
Net debt
40,690
52,890
80,740
Cash flow
Cash from operating activities
57,812
53,377
46,857
CAPEX
(22,679)
(14,031)
(10,575)
Cash from investing activities
(44,313)
(12,559)
(17,081)
Cash from financing activities
(24,366)
(31,446)
(30,796)
FCF
145,789
125,382
111,218
Balance
Cash
51,241
38,990
32,272
Long term investments
93
(16,489)
(20,628)
Excess cash
40,087
12,579
3,008
Stockholders' equity
87,165
93,086
29,879
Invested Capital
103,431
96,285
104,028
ROIC
159.00%
134.00%
120.30%
ROCE
119.20%
132.64%
119.29%
EV
Common stock shares outstanding
16,303
16,303
16,303
Price
23.00
31.43%
17.50
-17.45%
21.20
50.35%
Market cap
374,961
31.43%
285,303
-17.45%
345,624
50.37%
EV
416,930
339,217
427,154
EBITDA
188,668
159,738
142,130
EV/EBITDA
2.21
2.12
3.01
Interest
572
419
458
Interest/NOPBT
0.33%
0.29%
0.36%